sulfonylureas


Also found in: Thesaurus, Medical, Wikipedia.
Related to sulfonylureas: Thiazolidinediones

sulfonylureas

These reduce the levels of glucose in the blood and are used to treat diabetes mellitus.
References in periodicals archive ?
Until 1994, the only drug options in the United States were sulfonylureas and insulin.
has received clearance from the Food and Drug Administration to market Rezulin (troglitazone) for Type 2 diabetes patients as monotherapy or combination therapy with other commonly used agents known as sulfonylureas.
0 ml AVR118 given subcutaneously on blood glucose in subjects with type 2 diabetes who are on sulfonylureas and/or metformin, as compared to subjects not receiving AVR118.
For sulfonylureas, the hits keep coming, but so far they remain standing.
Effects of clinical outcomes of adding dipeptidyl peptidase-4 inhibitors versus sulfonylureas to metformin therapy in patients with type 2 diabetes mellitus.
MEPs point out that sulfonylureas, which are a common second line option for managing type 2 diabetes, are also used as herbicides, as they are highly toxic to plants at very low doses.
lc], weight, and cardiovascular mortality versus sulfonylureas, as well as its relative safety profile, Dr.
The evidence from this systematic review supports current type 2 diabetes guidelines that recommend metformin as the first-line agent to treat adults, based on its beneficial effects on hemoglobin Alc level, weight, and cardiovascular mortality, versus sulfonylureas, as well as its relative safety profile, Dr.
STOCKHOLM -- Sulfonylureas seem to substantially increase the risk for cardiovascular events relative to other antihyperglycemic agents, although they are effective glucose-lowering agents, according to several presentations given at the annual meeting of the European Association for the Study of Diabetes.
The order they were given was according to the understanding of diabetes then, which was that diabetes was primarily a lack of insulin, so sulfonylureas were first to be given.
Keywords: Metformin intolerance, type 2 diabetes, sulfonylureas, alpha glucosidase inhibitors, pioglitazone, SGLT2 inhibitors, DPP4 inhibitors.
Sulfonylureas increase insulin production and release from the beta cells of the pancreas.